Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Fibroblast growth factor 23 levels before and after renal transplantation

The Egyptian Journal of Internal Medicine volume 28, pages 52–59 (2016)Cite this article

Abstract

Background

Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate reabsorption and calcitriol production by the kidney, has uncovered primary regulatory pathways and new systems biology governing bone mineralization, vitamin D metabolism, parathyroid gland function, and renal phosphate handling.

Aim of the work

The aim of the present prospective study was to investigate FGF23 levels in patients with end-stage renal disease before and after a successful renal transplant and their probable association with the markers of bone and mineral metabolism.

Patients and methods

A total of 40 patients were studied for 6 months and divided into two groups (hemodialysis vs. renal transplant patients). Serum FGF23, calcium, phosphorus, and intact parathyroid hormone (iPTH) were estimated for both groups. We compared the changes in serum FGF23, calcium, phosphorus, and iPTH in renal transplant patients 3 and 6 months after successful renal transplantation. Results

The serum FGF23 decreased significantly after renal transplantation. iPTH and P levels also decreased significantly after renal transplant, whereas Ca level increased.

Conclusion

FGF23 levels were markedly increased in patients with end-stage renal disease associated with an increase in phosphorous and iPTH levels. FGF23 levels decrease dramatically after successful renal transplantation and remain within the normal limits when graft function is good. iPTH and P levels also decrease significantly after renal transplantation, whereas Ca increases.

References

  1. Silver J, Naveh-Many T. FGF23 and the parathyroid glands. Pediatr Nephrol 2013; 25: 2241–2245.

    Article  Google Scholar 

  2. Stubbs JR, He N, Idiculla A. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease. J Bone Miner Res 2012; 1: 38–46.

    Article  Google Scholar 

  3. Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82: 737–747.

    Article  CAS  Google Scholar 

  4. Evenepoel P, Viaene L, Meijers B. PTH, FGF23, and calcium: it takes three to tango? Kidney Int 2011; 80: 1377.

  5. Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators. Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 2015; 11: 656–666.

    Article  CAS  Google Scholar 

  6. Cianciolo G, Capelli I, Angelini ML, Valentini C, Baraldi O, Scolari MP, Stefoni S. Importance of vascular calcification inkidney transplant recipients. Am J Nephrol 2014; 39: 418–426.

    Article  CAS  Google Scholar 

  7. Torregrosa JV, Bover J, Cannata Andía J, Lorenzo V, de Francisco AL, Martínez I et al. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrologia 2011; 31: (Suppl 1): 3–32.

    PubMed  Google Scholar 

  8. Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant 2015; 5: 231–242.

    Article  Google Scholar 

  9. Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol 2013; 9: 641–649.

    Article  CAS  Google Scholar 

  10. Economidou D, Dovas S, Papagianni A. FGF23 before and after renal transplantation. J Transplant 2009; 10: 1–5.

    Article  Google Scholar 

  11. Krocker D, Perka C, Tuischer J. Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells. Transplant Int 2006; 19: 563–569.

    Article  CAS  Google Scholar 

  12. Trombetti A, Richert L, Hadaya K, Graf JD, Herrmann FR, Ferrari SLet al. Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur J Endocrinol 2011; 164: 839–847.

    Article  CAS  Google Scholar 

  13. Heaf JG. Bone disease after renal transplantation. Transplantation 2003; 75: 315.

    Article  Google Scholar 

  14. Saji F, Shiizaki K, Shimada S. Regulation of fibroblast growth factor 23 production in bone in uremic rats. Nephron Physiol 2009; 111: 59–66.

    Article  Google Scholar 

  15. Borchhardt K, Sulzbacher I, Benesch T. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant 2007; 7: 2515.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Internal Medicine, Cairo University, Kasr Alainy Street, 11562, Egypt

    Mohamed M. El-khatib, Sahier O. EEl-Khashab, Eman El. Mohamed MD & Amr M. Shaker

  2. Biochemistry, Faculty of Medicine, Cairo University, Egypt

    Amal R. El-Shahaby

Authors
  1. Mohamed M. El-khatib
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amal R. El-Shahaby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sahier O. EEl-Khashab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eman El. Mohamed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amr M. Shaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eman El. Mohamed MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-khatib, M.M., El-Shahaby, A.R., EEl-Khashab, S.O. et al. Fibroblast growth factor 23 levels before and after renal transplantation. Egypt J Intern Med 28, 52–59 (2016). https://doi.org/10.4103/1110-7782.193887

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.193887

Keywords